Fate Therapeutics Inc. Common Stock (FATE)
FairStock Score: 55/100 — STEADY
| Current Price | $1.35 |
| Market Cap | $15,63,74,352 |
| P/E Ratio | — |
| ROE | -51.84% |
| Dividend Yield | —% |
| Sector | Healthcare |
Data from SEC filings. Not investment advice. Scoring methodology
FairStock Score: 55/100 — STEADY
| Current Price | $1.35 |
| Market Cap | $15,63,74,352 |
| P/E Ratio | — |
| ROE | -51.84% |
| Dividend Yield | —% |
| Sector | Healthcare |
Data from SEC filings. Not investment advice. Scoring methodology